Close
Smartlab Europe
Inizio Ignite

Amgen Donates $1 Million to Help Japanese Disaster Victims

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Addressing the Boomers: How Pharma Must Adapt Drug Development for the 65+ Demographic

An aging population is reshaping medicine. Why pharma must...

GCCL, Medicover Sign MOU for Clinical Trial Services Expansion

GCCL Co., Ltd. (GCCL) and Medicover Integrated Clinical Services...

Novartis Breaks Ground on San Diego Biomedical R&D Site

Novartis has started work on a $1.1 billion biomedical...
- Advertisement -

Amgen announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to both Direct Relief International and International Medical Corps to bring basic needs and vital health services to those affected in Japan. Amgen has a long history in Japan with our partnership with Kirin Holdings and its pharmaceutical affiliate Kyowa Hakko Kirin that began in 1984, and more recently partnerships with Takeda Pharmaceutical and Daiichi Sankyo.

Kevin Sharer, Amgen’s chairman and chief executive officer said, The earthquake and subsequent tsunami in Japan have been devastating to so many people throughout the country. Our sincere sympathy goes to all of those in Japan affected by this tragedy

Latest stories

Related stories

Addressing the Boomers: How Pharma Must Adapt Drug Development for the 65+ Demographic

An aging population is reshaping medicine. Why pharma must...

GCCL, Medicover Sign MOU for Clinical Trial Services Expansion

GCCL Co., Ltd. (GCCL) and Medicover Integrated Clinical Services...

Novartis Breaks Ground on San Diego Biomedical R&D Site

Novartis has started work on a $1.1 billion biomedical...

Bristol Myers Evinova Partnership Targets AI-Led Trials

Bristol Myers Squibb has entered a global agreement with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »